Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Lisa Wilson - IR Scott Tarriff - Founder, President, CEO & Director Brian Cahill - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Lachlan Hanbury-Brown - William Blair & Company David Amsellem - Piper Sandler & Co. Operator Good morning, everyone. My name is Gretchen, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmac ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|-------------------------------------------------- ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q4 2021 Earnings Conference Call March 7, 2022 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Scott Tarriff - Founder, Chief Executive Officer, President Brian Cahill - Chief Financial Officer Conference Call Participants Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald David Amsellem - Piper Sandler Operator Good morning, everyone. My name is Ashley, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eag ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-36306 Eagle Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 2834 20-8179278 (State or Other J ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Scott Tariff - Chief Executive Officer Brian Cahill - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald David Amsellem - Piper Sandler Tim Lugo - William Blair Operator Good morning everyone. My name is Ashley, and I will be your conference Operator today. At this time, I would like to welcome everyone to Eagle Phar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|---------------------------------------------- ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q2 2021 Earnings Conference Call August 9, 2021 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Scott Tariff – Chief Executive Officer Judith Ng-Cashin – Chief Medical Officer Brian Cahill – Chief Financial Officer Conference Call Participants Brandon Folkes – Cantor Fitzgerald Tim Lugo – William Blair Steve Arthur – RBC Capital Markets Jack Hendricks – Piper Sandler Operator Good morning, everyone. My name is Keith and I will be your conference O ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|--------------------------------------------------- ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q1 2021 Earnings Conference Call May 10, 2021 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Scott Tarriff - Chief Executive Officer Brian Cahill - Chief Financial Officer Conference Call Participants Tim Lugo - William Blair Daniel Busby - RBC Capital Markets David Amsellem - Piper Sandler Brandon Folkes - Cantor Fitzgerald Operator Good morning, everyone. My name is Leo, and I will be your conference operator. At this time, I’d like to welcome ev ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|-------------------------------------------------- ...